The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 18, 2018
Filed:
Jan. 31, 2018
Applicants:
Purdue Pharma L.p., Stamford, CT (US);
Purdue Pharmaceuticals L.p., Wilson, NC (US);
Inventors:
William H. McKenna, Yonkers, NY (US);
Richard O. Mannion, Furlong, PA (US);
Edward P. O'Donnell, Basking Ridge, NJ (US);
Haiyong H. Huang, Princeton, NJ (US);
Assignees:
Purdue Pharma L.P., Stamford, CT (US);
Purdue Pharmaceuticals L.P., Wilson, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61K 9/20 (2006.01); A61K 9/16 (2006.01); A61J 3/06 (2006.01); A61K 9/00 (2006.01); A61K 31/485 (2006.01); A61K 47/34 (2017.01); A61K 47/10 (2017.01); A61K 45/06 (2006.01); A61K 9/24 (2006.01); A61J 3/10 (2006.01); B29C 43/00 (2006.01); A61J 3/00 (2006.01); B29C 37/00 (2006.01); B29C 43/52 (2006.01); B29B 7/88 (2006.01); B29C 35/04 (2006.01); B29B 7/02 (2006.01); B29C 35/16 (2006.01); B29C 43/02 (2006.01); B29C 71/00 (2006.01); B29K 71/00 (2006.01); B29K 105/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/28 (2013.01); A61J 3/005 (2013.01); A61J 3/06 (2013.01); A61J 3/10 (2013.01); A61K 9/0002 (2013.01); A61K 9/0053 (2013.01); A61K 9/1641 (2013.01); A61K 9/209 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 9/284 (2013.01); A61K 9/2853 (2013.01); A61K 9/2866 (2013.01); A61K 9/2893 (2013.01); A61K 31/485 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); B29B 7/02 (2013.01); B29B 7/88 (2013.01); B29C 35/045 (2013.01); B29C 35/16 (2013.01); B29C 37/0025 (2013.01); B29C 43/003 (2013.01); B29C 43/02 (2013.01); B29C 43/52 (2013.01); B29C 71/00 (2013.01); B29C 71/009 (2013.01); A61K 9/2072 (2013.01); B29C 2035/046 (2013.01); B29C 2035/1658 (2013.01); B29K 2071/02 (2013.01); B29K 2105/0035 (2013.01); B29K 2105/251 (2013.01); B29K 2995/0088 (2013.01); B29L 2031/753 (2013.01);
Abstract
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.